We use cookies to understand how you use our site and to improve your experience.
This includes personalizing content and advertising.
By pressing "Accept All" or closing out of this banner, you consent to the use of all cookies and similar technologies and the sharing of information they collect with third parties.
You can reject marketing cookies by pressing "Deny Optional," but we still use essential, performance, and functional cookies.
In addition, whether you "Accept All," Deny Optional," click the X or otherwise continue to use the site, you accept our Privacy Policy and Terms of Service, revised from time to time.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
Wall Street delivered a decent performance last month with the S&P 500 and the Dow Jones adding 1.5% each and the Nasdaq Composite gaining about 3.1%. The Russell 2000 Index has advanced about 2.3% past month.
A few updates led to this result. Optimism about corporate earnings and upbeat economic data points and the passage of the infrastructure bill helped key U.S. equity indexes go higher. News of zero new cases in China and U.S. FDA’s full approval of Pfizer-BioNTech Covid-19 vaccine also led to the strength in the market.
However, taper talks were ripe in the month, which unsteadied the market momentum initially. But things ended the month on a better note with no new flare-up in taper talks and the moderate strength in the greenback.
Against this backdrop, below we highlight a few ETFs that won last month.
Blockchain
Bitcoin rallied near $49,000 on the back of rising mainstream acceptance. Investors probably chose to invest in bitcoin-related products through much stable investing options like blockchain or digital transformation ETFs. As a result, the following ETFs shot up last month.
The Solactive Blockchain Index provides exposure to companies that are positioned to benefit from further advances in the field of blockchain technology.
Vaneck Digital Transformation ETF (DAPP) – Up 20.6%
Shipping
Gradual global reopening continues to help this fund. A commodity boom is driving the prices as demand for shipping is high. Ultra-easy monetary and fiscal policies as well as supply chain issues and higher demand from e-commerce companies are also boosting the shipping ETF BDRY. The underlying Capesize 5TC Index, Panamax 4TC Index & Supramax 6TC Index measure rates for shipping dry bulk freight. (read: This Multibagger ETF Still Looks Like a Buy: Here's Why).
Most Latin American currencies rallied recently as U.S. Federal Reserve Chair Jerome Powell apparently reassured markets for some more days of super-easy monetary policy.
The COVID-19 pandemic and the resultant work-learn-shop-from-home culture boosted the need for the already in-vogue digitization, accelerating the demand for various products and devices dependent on chips for their functioning.
Demand for PCs, smart phones, gaming hardware and consoles increased. Then there is demand rooting from the electric vehicle and telecom industry. All these products rely on chips, which boosted the demand for semiconductors (read: Semiconductor ETFs A Great Bet Now: Here's Why).
Delta variant continues to be a major concern as the number of cases is rising in the world’s largest economy. Hence, the stay-at-home trend and greater focus on online activities like eSports will be in focus.
The biotech space has gained attention on positive COVID-19 vaccine update. The FDA has granted the first full U.S. approval to Pfizer (PFE) /BioNTech’s (BNTX) coronavirus vaccine. There were more positive news in the space. Sanofi has agreed to acquire U.S. biotech company Translate Bio in a $3.2 billion deal, as it wants to strengthen its position in the next-generation mRNA vaccine technology. Pfizer agreed to buy Canadian drug developer Trillium Therapeutics (TRIL) for a $2.26 billion deal to strengthen its arsenal of blood cancer therapies.
Etfmg Treatments Testing and Advancements ETF – Up 11.95%
See More Zacks Research for These Tickers
Normally $25 each - click below to receive one report FREE:
Image: Bigstock
6 Best ETF Areas of August
Wall Street delivered a decent performance last month with the S&P 500 and the Dow Jones adding 1.5% each and the Nasdaq Composite gaining about 3.1%. The Russell 2000 Index has advanced about 2.3% past month.
A few updates led to this result. Optimism about corporate earnings and upbeat economic data points and the passage of the infrastructure bill helped key U.S. equity indexes go higher. News of zero new cases in China and U.S. FDA’s full approval of Pfizer-BioNTech Covid-19 vaccine also led to the strength in the market.
However, taper talks were ripe in the month, which unsteadied the market momentum initially. But things ended the month on a better note with no new flare-up in taper talks and the moderate strength in the greenback.
Against this backdrop, below we highlight a few ETFs that won last month.
Blockchain
Bitcoin rallied near $49,000 on the back of rising mainstream acceptance. Investors probably chose to invest in bitcoin-related products through much stable investing options like blockchain or digital transformation ETFs. As a result, the following ETFs shot up last month.
The Solactive Blockchain Index provides exposure to companies that are positioned to benefit from further advances in the field of blockchain technology.
Global X Blockchain ETF (BKCH - Free Report) – Up 22%
Vaneck Digital Transformation ETF (DAPP) – Up 20.6%
Shipping
Gradual global reopening continues to help this fund. A commodity boom is driving the prices as demand for shipping is high. Ultra-easy monetary and fiscal policies as well as supply chain issues and higher demand from e-commerce companies are also boosting the shipping ETF BDRY. The underlying Capesize 5TC Index, Panamax 4TC Index & Supramax 6TC Index measure rates for shipping dry bulk freight. (read: This Multibagger ETF Still Looks Like a Buy: Here's Why).
Breakwave Dry Bulk Shipping ETF (BDRY - Free Report) – Up 21.8%
Argentina
Most Latin American currencies rallied recently as U.S. Federal Reserve Chair Jerome Powell apparently reassured markets for some more days of super-easy monetary policy.
Global X MSCI Argentina ETF (ARGT - Free Report) – Up 16.4%
Argentina iShares MSCI ETF (AGT) – Up 16.1%
Semiconductors
The COVID-19 pandemic and the resultant work-learn-shop-from-home culture boosted the need for the already in-vogue digitization, accelerating the demand for various products and devices dependent on chips for their functioning.
Demand for PCs, smart phones, gaming hardware and consoles increased. Then there is demand rooting from the electric vehicle and telecom industry. All these products rely on chips, which boosted the demand for semiconductors (read: Semiconductor ETFs A Great Bet Now: Here's Why).
S&P Semiconductor SPDR (XSD - Free Report) – Up 13.9%
eSports
Delta variant continues to be a major concern as the number of cases is rising in the world’s largest economy. Hence, the stay-at-home trend and greater focus on online activities like eSports will be in focus.
Roundhill Sports Betting & iGaming ETF (BETZ - Free Report) – Up 12.9%
Biotech
The biotech space has gained attention on positive COVID-19 vaccine update. The FDA has granted the first full U.S. approval to Pfizer (PFE) /BioNTech’s (BNTX) coronavirus vaccine. There were more positive news in the space. Sanofi has agreed to acquire U.S. biotech company Translate Bio in a $3.2 billion deal, as it wants to strengthen its position in the next-generation mRNA vaccine technology. Pfizer agreed to buy Canadian drug developer Trillium Therapeutics (TRIL) for a $2.26 billion deal to strengthen its arsenal of blood cancer therapies.
Etfmg Treatments Testing and Advancements ETF – Up 11.95%